missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Human GPER/GPR30 Antibody, R&D Systems™

Goat Polyclonal Antibody has been used in 2 publications
Marque: R&D Systems AF5534
Les retours ne sont pas autorisés pour ce produit.
Afficher la politique du retour.
Description
GPER/GPR30 Polyclonal specifically detects GPER/GPR30 in Human samples. It is validated for Western Blot, Flow Cytometry, Immunohistochemistry.
Spécification
| GPER/GPR30 | |
| Polyclonal | |
| Unconjugated | |
| Q99527 | |
| GPER | |
| E. coli-derived recombinant human GPER Met1-Ser62 Accession # Q99527 | |
| 100 μg | |
| Primary | |
| Detects human GPER in direct ELISAs and Western blots. In direct ELISAs, less than 1% cross-reactivity with recombinant human GPR144, GPR115, and GPR124 is observed. | |
| Human | |
| IgG |
| Western Blot, Immunohistochemistry | |
| LYOPH | |
| Western Blot 1 ug/mL, Immunohistochemistry 5-15 ug/mL | |
| CEPR, CEPRG-protein coupled receptor 30, Chemoattractant receptor-like 2, chemokine receptor-like 2, CMKRL2, CMKRL2MGC99678, constitutively expressed peptide-like receptor, DRY12, DRY12IL8-related receptor DRY12, FEG-1, FEG-1mER, Flow-induced endothelial G-protein coupled receptor 1, G protein-coupled estrogen receptor 1, G protein-coupled receptor 30, GPCR-BR, GPR30, GPR30GPCR-Br, G-protein coupled estrogen receptor 1, heptahelix receptor, LERGU, LERGU2, leucine rich protein in GPR30 3'UTR, LyGPR, Lymphocyte-derived G-protein coupled receptor, Membrane estrogen receptor | |
| Goat | |
| Affinity Purified | |
| RUO | |
| 2852 | |
| Reconstitute at 0.2 mg/mL in sterile PBS. | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
Correction du contenu d'un produit
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.
Nom du produit
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu